HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)

glutamate agonist
Also Known As:
beta-methylamino-L-alanine; 2-amino-3(methylamino)propionic acid; L-BMAA; alpha-amino-beta-methylaminopropionate
Networked: 74 relevant articles (0 outcomes, 6 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Muñoz-Sáez, Emma: 6 articles (01/2016 - 03/2013)
2. de Munck, Estefanía: 5 articles (01/2016 - 01/2013)
3. Lobner, Doug: 4 articles (09/2020 - 02/2007)
4. Banack, Sandra Anne: 4 articles (01/2018 - 09/2006)
5. Cox, P A: 4 articles (01/2018 - 10/2004)
6. Martínez, Ana: 4 articles (01/2016 - 09/2013)
7. Solas, M Teresa: 4 articles (01/2016 - 01/2013)
8. Miguel, Begoña G: 4 articles (05/2015 - 01/2013)
9. Caller, Tracie A: 4 articles (01/2012 - 01/2009)
10. Stommel, Elijah W: 4 articles (01/2012 - 01/2009)

Related Diseases

1. Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
2. Neurodegenerative Diseases (Neurodegenerative Disease)
3. Dementia (Dementias)
4. Alzheimer Disease (Alzheimer's Disease)
5. Motor Neuron Disease (Primary Lateral Sclerosis)

Related Drugs and Biologics

1. Neurotoxins
2. Amino Acids
3. Alanine (L-Alanine)
4. oxalyldiaminopropionic acid
5. beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)
6. Proteins (Proteins, Gene)
7. Cyanobacteria Toxins
8. Cycasin
9. Heavy Metals
10. Glutamic Acid (Glutamate)

Related Therapies and Procedures

1. Intravenous Injections
2. Injections